Reunited Spraoi-alumni team on $3M of seed. Two independent third-party voices — an SI/BPO channel partner and an E&S MGA buyer — confirm production deployment at sophisticated insurance customers. But a publicly nameable Tier-1 competitor (Pace) now anchors Tier-1 European insurer in the same $5B+ segment Stitch claims, with 3-4x the funding. The diligence question: can a $3M-seed channel-led play win the Tier-1 carrier wedge against a $10M Sequoia-led direct-sale competitor that already has a named anchor?
May 2026
AI automation across intake, quote compare, policy checking, servicing, and renewals — layered on AMS systems (Applied Epic, AMS360, HawkSoft, Nexsure). Document-heavy lifecycle automation; brokerage-specialist category.
Outmarket (~$21.7M total; $17M Series A May 2026, Permanent Capital Ventures); Fulcrum ($25M Series A Jan 2026, CRV)
Buyer: US commercial brokerages (Tier 2 + long tail)
Pre-built workflows + off-the-shelf Duck Creek/Guidewire integrations + FDE for enterprise. MGA-anchored today, expanding into carriers; brokerage as secondary segment[24].
FurtherAI ($30M, a16z — Specialty MGA carrier + Tier-2 MGA carrier named)
Buyer mix: MGAs primary (~70% of revenue Q1'26), carriers as next frontier, brokerages secondary. Sold to CIO/CTO as productivity tool / IT budget.
Real ICP, per cross-vendor expert [24]: Stitch markets to all four buyer types (carriers, MGAs, TPAs, brokers)[1][6], but an SI/BPO channel partner running Stitch in production at multiple anonymous client carriers places its real fit at the $5B+ Tier-1 carrier wedge — where workflows are custom and bespoke, and the ~300-400 micro-agent composability matters. FurtherAI is cross-segment (MGAs primary at ~70% of Q1'26 revenue, carriers as next frontier, brokerages secondary) and sits in the mid-market on pre-built workflow strength sold into IT/innovation budget[24]. Pace (Sequoia, $10M) is also in the $5B+ Tier-1 segment, but with a different value-prop (BPO replacement) and a publicly named anchor (Tier-1 European insurer)[26].
Santoash Rajaram (Founder & CPTO) — CMU MS Information Systems Mgmt. Senior Engineering Leader at Apple 2009-2017 (8.5 years).[12] Co-founded Spraoi 2017; Spraoi acquired by FINEOS[7] (Rajaram’s Spraoi tenure ended Oct 2024 per Specter[12]; underlying acquisition-close date not independently confirmed).
Karan Mishra (CEO, joined Jul 22 2025) — CMU MISM. Principal at EY Dec 2022 - Jun 2025 (insurance practice); EY Executive Director Apr 2015 - Jun 2017 prior to Spraoi.[12] Co-founded Spraoi Jun 2017 - May 2022 (~5y).[14] 9 years prior at Deloitte Consulting Sr. Manager.
Mamta Chaurdia (Pre-Sales & Client Success) — ex-Spraoi product leadership; ~19 years insurance.[1]
Three of eight publicly-named leaders are ex-Spraoi. The CEO addition came two weeks after seed announcement[9] — almost certainly priced into the round.
HQ: Chicago, IL (Specter Apr 2026)[12] — founder Rajaram in Portland, OR[13]; CEO Mishra in Chicago[14]. Real HQ effectively distributed.
Investors: Matt Kinley (ManchesterStory founding partner), BrokerTech Fund.[5] Joined BrokerTech Ventures cohort 2024[7].
| Company | Funding | Lead | Headcount | Named customers |
|---|---|---|---|---|
| Stitch | $3M Seed[4] | ManchesterStory + BTV | 32[12] | 0 |
| FurtherAI | $30M Series A | a16z | 36 | Specialty MGA carrier, Tier-2 MGA carrier |
| Pace | $10M Series A | Sequoia | ~12-15 | Tier-1 European insurer (anchor) |
| Fulcrum | $25M (Seed+A) | CRV | ~30-40 | ~1/3 top-50 US brokers |
| Outmarket | ~$21.7M total ($17M Series A May 2026) | Permanent Capital Ventures | 15 | 250+ brokers (incl. Top-100) |
Cohort funded peers per Altis InsurTech sector context (May 2026). Stitch is the only company in the segment with zero publicly-named customers as of 2026-05-15.
| Department | Count | % |
|---|---|---|
| Engineering | 9 | 28% |
| Strategy & CorpDev | 9 | 28% |
| Senior Leadership | 6 | 19% |
| Product & Research | 3 | 9% |
| BD & Marketing | 2 | 6% |
| Other | 3 | 9% |
Engineering at 28% is low for a workflow-AI company. Strategy & CorpDev tied at 28% suggests a services-heavy enterprise sales motion, not pre-built / self-serve product. Consistent with white-glove implementation — and with the team's stated lesson from Spraoi where deployments took 6-12 months[8].
Headcount trajectory: 6 (Jun 2024) → 9 (Apr 2025 seed close) → 17 (Jul 2025 announce) → 22 (Dec 2025) → 32 (Apr 2026). 5x growth in 22 months.
| Weeks | Phase |
|---|---|
| 1-2 | Connect (data integration) |
| 3-5 | Contextualize (knowledge graph) |
| 6-8 | Quality assurance |
| 9-12 | Launch |
“Insurers didn’t want another chatbot. They needed operational transformation without the black box.”
Founder-engineer (Rajaram, ex-Apple data & workflow engineering) + operator-CEO (Mishra, ex-Big Four insurance consulting). Conventional B2B insurtech split. The 5-year prior working relationship at Spraoi reduces the typical risk of CEO/founder conflict[9].
Rajaram’s public framing of the Spraoi-era pain is the explicit thesis behind Stitch’s 12-week pre-built agent cycle: deployments at Spraoi took 6–12 months because every implementation was hand-built. The current product wager — ~300–400 reusable micro-agents composed via no-code workflows — is the structured response[24].
ITC Vegas 2025 main-stage Deloitte panel for Mishra (Oct 15)[11] — three months after his appointment. Former EY Principal making it onto a Deloitte main-stage suggests carrier and consultancy relationships came pre-built.
“Every client deployment took six to twelve months. The reality is, AI has to be organizationally specific.”
Read: Advisor roster is marketing-led but reveals real network density. Spraoi outcome (FINEOS acquisition) was sub-venture-scale; the agentic-AI bet must structurally change the ceiling.
| Company | Funding / Lead | Real segment fit | Tier-1 anchor | Value-prop framing | Pricing model |
|---|---|---|---|---|---|
| Stitch Studio | $3M Seed ManchesterStory + BTV[4] | $5B+ Tier-1 carriers (production confirmed[23][25]) | None named publicly (production-confirmed anonymous) | Augment ops team via custom micro-agent flows[8] | Not disclosed |
| Pace | $10M Series A Sequoia | $5B+ Tier-1 carriers (Top-5 US life insurer live[26]; Tier-1 EU Apr 2026) | Top-5 US life insurer (Pace anchor)[26] | Replace BPO contract (end-to-end Individual Life) | BPO-replacement / operating-budget displacement; per-license + man-hours[26] |
| FurtherAI | $25M Series A a16z (~$30M total) | Cross-segment: MGAs primary (~70% of Q1'26 revenue), carriers next frontier, brokerages secondary[24] | Specialty MGA carrier, Tier-2 MGA carrier named publicly | Pre-built workflows + Duck Creek/Guidewire starter packs + FDE for enterprise | Usage-based productivity tool (IT/innovation budget — CIO/CTO) |
| Fulcrum | $25M Series A CRV | US commercial brokerages (Tier 2) | Heffernan, Three Arbor + Tier-2 brokers | AI automation across intake, quote compare, policy checking | Subscription brokerage platform (IT budget) |
| Outmarket | ~$21.7M total ($17M Series A May 2026) Permanent Capital Ventures | US commercial brokerages (Tier 2 + long tail; 250+ customers) | Commercial Insurance Associates + Top-100 brokers | AI automation on AMS systems (intake, quoting, policy checking, servicing) | Subscription / seat-based AMS-integrated platform |
“Stitch Studio is probably best suited for the larger tier ones — anybody in the $5 billion and above range.”
Unresolved question: is the $5B+ Tier-1 segment large enough for both an augmentation play (Stitch) and a replacement play (Pace) at the same buyers on different budget lines — or does the 5→2 consolidation eventually pick one? The MGA-buyer evidence[25] (Pace + FurtherAI co-usage at one customer) leans toward “large enough.” The funding gap leans toward “Stitch wrong-side-of-consolidation.”
Two independent third-party voices [23][25] now confirm Stitch in production at sophisticated insurance customers. The single biggest remaining diligence unlock is a publicly nameable Tier-1 carrier reference — commissionable via the SI/BPO partner channel [23]. The Pace anchor reference [26] sets the comparison floor: any Stitch-side customer reference should target a quantified outcome at the same buyer profile.
1. Informational Purposes Only: This report is provided for informational purposes only and does not constitute investment, legal, tax, accounting, or other professional advice. Altis Ventures, Inc. (“Altis”) is not an investment advisor and does not provide financial advice or financial services. Each recipient is solely responsible for its own investment decisions, including evaluating the merits and risks of any transaction, and should consult its own advisers as it deems appropriate.
2. No Recommendation or Solicitation: Nothing in this report should be interpreted as a recommendation, offer, or solicitation by Altis (or any of its affiliates, officers, employees, or contractors) to buy, sell, or hold any security or to pursue any investment strategy. Any reference to a security, issuer, transaction, or strategy is illustrative and does not constitute a view that any such investment is appropriate or suitable for any particular investor.
3. No Reliance: Recipients may not rely on this report as the basis for any investment decision. Any decisions, acts, or omissions taken by a recipient in reliance on any portion of this report are taken at the recipient’s sole risk. Each recipient agrees to conduct its own independent investigation and analysis, to not treat this report as a substitute for its own diligence, and to rely solely on its own judgment and the advice of its own professional advisers.
4. No Guarantee of Accuracy: This report may include information or data obtained from third party sources, company provided materials, expert interviews, or other external inputs, as well as analyses generated with the assistance of artificial intelligence (“AI”) and other analytical tools. Altis believes such information to be from reliable sources but does not independently verify all data and makes no representation or warranty, express or implied, as to the accuracy, completeness, quality, or reliability of any information or opinion contained herein. Any estimates, projections, or forward looking statements are inherently uncertain and may differ materially from actual results.
5. AI-Assisted Analysis: Portions of this report may have been produced, summarized, or synthesized through use of AI. AI and machine learning are rapidly evolving fields of study, and given the probabilistic nature of machine learning, use of these tools can introduce errors, omissions, or biases, and recipients should not assume the outputs to be free from mistake or misinterpretation. All AI-assisted content is subject to human review, but no assurance is given that such review will identify or correct all issues.
6. Opinions and Forward-Looking Statements: Any views or opinions expressed in this report are those of Altis as of the date indicated and are subject to change without notice. Analyses may be based on assumptions, models, or frameworks selected by Altis that may prove to be incorrect or incomplete. Forward-Looking statements, scenario analyses, and other projections are inherently speculative and are subject to change continually and without notice of any kind and may no longer be true after the date indicated; they are not predictions or guarantees of future performance.
7. No Duty to Update. 8. No Redistribution. 9. No Fiduciary Relationship.
10. Conflicts and Interests: Altis, its affiliates, or their personnel may from time to time have relationships with, or economic interests in, entities referenced in this report.
11. Warranty Disclaimer: THE REPORT IS PROVIDED ON AN “AS IS” BASIS.
12. Limitation of Liability: Altis’s aggregate liability shall not exceed $100.